Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Comprehensive Drift-Adaptive Framework for Sustaining Model Performance in COVID-19 Detection From Dynamic Cough Audio Data: Model Development and Validation.

Journal of medical Internet research·2025
Same author

Parenting Styles and Psychosocial Factors of Mother-Child Dyads Participating in the ENDORSE Digital Weight Management Program for Children and Adolescents during the COVID-19 Pandemic.

Children (Basel, Switzerland)·2024
Same author

The smarty4covid dataset and knowledge base as a framework for interpretable physiological audio data analysis.

Scientific data·2023
Same author

Long Short-term Memory-Based Prediction of the Spread of Influenza-Like Illness Leveraging Surveillance, Weather, and Twitter Data: Model Development and Validation.

Journal of medical Internet research·2023
Same journal

Dual-Attention BiLSTM for Interpretable Forecasting of Treatment Toxicities.

... IEEE-EMBS International Conference on Biomedical and Health Informatics. IEEE-EMBS International Conference on Biomedical and Health Informatics·2026
Same journal

Personalized Case- and Evidence-Based TBI Prognosis with Small Language Models.

... IEEE-EMBS International Conference on Biomedical and Health Informatics. IEEE-EMBS International Conference on Biomedical and Health Informatics·2026
Same journal

Integrating Neuroimaging and Genetics via Contrastive Learning for Working Memory.

... IEEE-EMBS International Conference on Biomedical and Health Informatics. IEEE-EMBS International Conference on Biomedical and Health Informatics·2026
Same journal

Interrelation Among the Developmental Trajectories of Brain, Cognition and Behavior During Adolescence.

... IEEE-EMBS International Conference on Biomedical and Health Informatics. IEEE-EMBS International Conference on Biomedical and Health Informatics·2026
Same journal

Bidirectional Translation Between ECG and PCG.

... IEEE-EMBS International Conference on Biomedical and Health Informatics. IEEE-EMBS International Conference on Biomedical and Health Informatics·2026
Same journal

Caudal and Thalamic Segregation in White Matter Brain Network Communities in Alzheimer's Disease Population.

... IEEE-EMBS International Conference on Biomedical and Health Informatics. IEEE-EMBS International Conference on Biomedical and Health Informatics·2025
See all related articles

Related Experiment Video

Updated: Jul 4, 2026

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
09:47

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Published on: December 15, 2023

Source-Free Active Learning for Adapting Alzheimer's Diagnostic Deep Learning Models Across Neuroimaging Cohorts.

Theofanis Ganitidis1, Maria Eleftheria Vlontzou1, Maria Athanasiou1

  • 1School of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece.

... IEEE-EMBS International Conference on Biomedical and Health Informatics. IEEE-EMBS International Conference on Biomedical and Health Informatics
|July 3, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces an uncertainty-informed active learning method for Alzheimer's Disease (AD) classification across neuroimaging sites. The approach enhances model generalization by adapting to data variations without needing source data, achieving high diagnostic accuracy.

Keywords:
Alzheimer’s diseaseactive learningdeep learningdomain adaptationneuroimaginguncertainty estimation

More Related Videos

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

Related Experiment Videos

Last Updated: Jul 4, 2026

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
09:47

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Published on: December 15, 2023

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Alzheimer's Disease (AD) classification across multiple neuroimaging sites is hindered by domain shifts due to data heterogeneity.
  • Developing robust diagnostic models requires addressing variations in data acquisition, devices, and demographics.

Purpose of the Study:

  • To propose an uncertainty-informed active learning framework for Source-Free (SF) Domain Adaptation (DA) in AD classification.
  • To improve model generalization across diverse neuroimaging studies without requiring source domain data during deployment.

Main Methods:

  • Leveraged Monte Carlo dropout for estimating prediction uncertainty to guide sample selection from the target domain.
  • Employed an active learning strategy to adapt models using informative target samples.
  • Evaluated the framework on a large-scale dataset (3,177 participants) from five neuroimaging studies using regional brain volume measurements.

Main Results:

  • Achieved the highest median Area Under the Curve (AUC) of 91.4% across all source-target combinations, outperforming baseline models (89.7%).
  • Demonstrated superior performance compared to other SF and Source-Aware (SA) DA methods.
  • Quantified distribution shifts using maximum mean discrepancy to assess effectiveness under varying inter-site shifts.

Conclusions:

  • The proposed uncertainty-based active learning framework effectively addresses domain shifts in multi-site neuroimaging for AD classification.
  • SF methods can achieve performance comparable or superior to SA approaches while respecting data privacy constraints.
  • This approach enhances the robustness and generalizability of AD diagnostic models across different neuroimaging studies.